The Transplant Company Focused on better outcomes through personalized transplant surveillance. April 2020 Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding future financial position of CareDx, Inc. (together with its subsidiaries, "CareDx" or the "Company"), including financial targets, business strategy, and plans and objectives ...

CareDx, Inc (NASDAQ:CDNA) Q1 2020 Earnings Conference Call April 30, 2020 4:30 PM ET Company Participants Greg Chodaczek - Head of Investor Relations Peter Maag - Chief Executive Officer Michael Bell - Chief Financial Officer Reginald Seeto - Chief Business Officer Conference Call Participants Brandon Couillard - Jefferies & Company, Inc. Steven Mah - Piper Sandler Alexander Nowak - Craig-Hallum Capital Group LLC Andrew Cooper - Raymond James & Associates, Inc. Yi Chen - HC Wainwright Operator Good day and ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 _ ...

The Transplant Company Focused on better outcomes through personalized transplant surveillance. February 27, 2020 Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding future financial position of CareDx, Inc. (together with its subsidiaries, "CareDx" or the "Company"), including financial targets, business strategy, and plans and obje ...

CareDx Inc. (NASDAQ:CDNA) Q4 2019 Earnings Conference Call February 27, 2020 4:30 PM ET CompanyParticipants Greg Chodaczek - IR, Gilmartin Group Peter Maag - CEO Michael Bell - CFO Conference Call Participants Bill Quirk - Piper Sandler Brandon Couillard - Jefferies Alex Nowak - Craig-Hallum Capital Group Yi Chen - H.C. Wainwright & Co. Operator Greetings and welcome to CareDx Incorporated Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________ Form 10-K ________________________________________________________________________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-365 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 CAREDX, INC. (Exact name of registrant as specified in its charter) Delaware 94-3316839 (State or other jurisdiction of in ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 CAREDX, INC. (Exact name of registrant as specified in its charter) Delaware 94-3316839 (State or other jurisdiction of i ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36536 CAREDX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 94-3316839 (State or Other Jurisdiction of Incorpo ...